1. [ACE inhibitors continue to be first choice in the treatment of heart failure patients].
- Author
-
Gadsbøll N and Pedersen CT
- Subjects
- Angiotensin Receptor Antagonists adverse effects, Angiotensin Receptor Antagonists therapeutic use, Angiotensin-Converting Enzyme Inhibitors adverse effects, Humans, Review Literature as Topic, Ventricular Dysfunction, Left drug therapy, Angiotensin-Converting Enzyme Inhibitors therapeutic use, Heart Failure drug therapy
- Abstract
A new Cochrane metaanalysis has reviewed the literature on the use of angiotensin receptor blockers (ARB) in patients with heart failure and left ventricular systolic dysfunction. The conclusion supports the present recommendation from the European Society of Cardiology that angiotensin converting enzyme inhibitors (ACE-I) are first choice and that ARBs should be reserved to patients who are intolerant to ACE-Is. Neither ACE-Is nor ARBs are effective in the treatment of heart failure patients with normal left ventricular function.
- Published
- 2013